FDP
ALNY icon

Financiere des Professionnels’s Alnylam Pharmaceuticals ALNY Stock Holding History

Financiere des Professionnels’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.05M Buy
10,141
+7,452
+277% +$2.25M 0.17% 118
2026
Q1 		$890K Hold
2,689
– – 0.05% 200
2025
Q4 		$1.07M Buy
2,689
+885
+49% +$392K 0.06% 183
2025
Q3 		$823K Buy
+1,804
New +$735K 0.05% 196

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Financiere des Professionnels's ALNY Position: Q2 2026 in Review

Financiere des Professionnels increased its Alnylam Pharmaceuticals (ALNY) stake by 277% in Q2 2026, buying an estimated $2.25M and bringing the position to 10,141 shares worth $3.05M. The position accounts for 0.17% of the portfolio, ranked #118.

Financiere des Professionnels first reported a position in ALNY in Q3 2025 and has held it in 4 quarters since. 789 funds tracked by Wall St. Rank hold ALNY as of Q2 2026.

  • Financiere des Professionnels held 10,141 shares of Alnylam Pharmaceuticals worth $3.05M as of Q2 2026.
  • Financiere des Professionnels bought 7,452 Alnylam Pharmaceuticals shares in Q2 2026, an estimated $2.25M.
  • Alnylam Pharmaceuticals made up 0.17% of Financiere des Professionnels's portfolio in Q2 2026, its #118 holding.
  • Financiere des Professionnels first reported a position in Alnylam Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • 789 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2026.

Based on Financiere des Professionnels's 13F filing for Q2 2026, filed 5 Aug 2026.